Wave crashes on obesity drug update; Kodiak's reboot pays dividends [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
Today, a brief rundown of news from Wave Life Sciences and Kodiak Sciences, as well as updates from Pinnacle Medicines and Pulmatrix that you may have missed. Shares of Wave Life Sciences plummeted by more than 50% Thursday on updated early-stage study results for a drug it's testing in obesity. When compared to a placebo, a single, 240 milligram dose of the therapy, WVE-007 , led to a 14% reduction in harmful “visceral” fats and a 3% decline in waist circumference after six months. However, a higher dose didn't appear more to be more potent, and participants lost only 1% of their body weight and 5% of total fat over that timeframe, numbers that fell short of Wall Street benchmarks heading into the results. Still, some analysts rose to Wave's defense. Leerink Partners' Joseph Schwartz wrote that while the results “may be disappointing on the surface,” the therapy's steady impact on measures of body composition were encouraging. Those effects showcase the drug's “differentiated mech
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Is This Weight Loss Drug Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight Loss [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 2/26/26 - Miss
WVE
Sec Filings
- 3/30/26 - Form SCHEDULE
- 3/30/26 - Form 4
- 3/26/26 - Form 4
- WVE's page on the SEC website